Books > Medicine > Clinical & internal medicine > Diseases & disorders > Infectious & contagious diseases
|
Buy Now
Rapid Medical Countermeasure Response to Infectious Diseases - Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary (Paperback)
Loot Price: R1,309
Discovery Miles 13 090
|
|
Rapid Medical Countermeasure Response to Infectious Diseases - Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships: Workshop Summary (Paperback)
Expected to ship within 12 - 17 working days
|
Emerging infectious disease threats that may not have available
treatments or vaccines can directly affect the security of the
world's health since these diseases also know no boundaries and
will easily cross borders. Sustaining public and private investment
in the development of medical countermeasures (MCMs) before an
emerging infectious disease becomes a public health emergency in
the United States has been extremely challenging. Interest and
momentum peak during a crisis and wane between events, and there is
little interest in disease threats outside the United States until
they impact people stateside. On March 26 and 27, 2015, the
Institute of Medicine convened a workshop in Washington, DC to
discuss how to achieve rapid and nimble MCM capability for new and
emerging threats. Public- and private-sector stakeholders examined
recent efforts to prepare for and respond to outbreaks of Ebola
Virus Disease, pandemic influenza, and coronaviruses from policy,
budget, and operational standpoints. Participants discussed the
need for rapid access to MCM to ensure national security and
considered strategies and business models that could enhance
stakeholder interest and investment in sustainable response
capabilities. This report summarizes the presentations and
discussions from this workshop. Table of Contents Front Matter 1
Introduction 2 A Wake-Up Call: The 2014 Ebola Outbreak Response 3
Preparedness as an Issue of National Security 4 Rapid Development
of Ebola Vaccines 5 Influenza Risk Assessment and Pandemic
Preparedness 6 Developing MCMs for Coronaviruses 7 Sustainable
Business Models to Ensure Rapid and Nimble Responses 8 Supporting
MCM Development Across Threats and Funding Cycles A References B
Acronyms and Abbreviations C Statement of Task D Agenda E
Biosketches of Invited Speakers and Facilitators
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.